Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 45× · first seen 09-sep-2026 · last seen 13-nov-2026

Senomorphics

Current understanding

To be populated as evidence accumulates.

Evidence log

Open questions

Related

Contributing findings

rss news report mechanism-plausible
Interfering in the USP25-SIRT1 Interaction Reduces the Onset of Cellular Senescence
13-nov-2026 novelty 3 per-area 3 strengthens
pubmed preclinical
Sanmiao San Attenuates D-galactose-induced Chondrocyte Senescence by Regulating the FoxM1-p21 Signaling Pathway.
12-nov-2026 novelty 2 per-area 2 strengthens
pubmed review
Senescence-Associated Secretory Phenotype (SASP) and Atherosclerotic Plaque Inflammation: Natural Product-Based Interventions and Implications for Personalized Therapy.
10-nov-2026 novelty 2 per-area 2 strengthens
pubmed review
The neuro-inflammaging triangle: a self-amplifying circuit of protein pathology, senescence-associated secretory phenotype and innate immunity in neurodegenerative disease.
10-nov-2026 novelty 3 per-area 2 mentions
pubmed review mechanism-plausible
Intervening in Adipocyte Senescence: Lipid Prodrugs as an Emerging Strategy for Metabolic Disease Treatment.
29-oct-2026 novelty 3 per-area 3 strengthens
pubmed review expert-opinion
Biomarker-Guided, Stage-Specific Senotherapy for Metabolic Dysfunction-Associated Steatotic Liver Disease.
08-oct-2026 novelty 3 per-area 3 strengthens
pubmed review
Is there a role for senotherapeutics in the treatment of giant cell arteritis?
07-oct-2026 novelty 2 per-area 2 mentions
pubmed review expert-opinion
Nanoparticle-based senolytic and senomorphic therapies for healthy aging: design principles, translational evidence, and challenges.
07-oct-2026 novelty 3 per-area 3 strengthens
rss review
Endothelial TLR4 at the Crossroads of Vascular Senescence and Targeted Senotherapeutics
06-oct-2026 novelty 2 per-area 2 mentions
rss preclinical animal-model
Novel Flavonoid Senotherapeutics Identified by Phenotypic Drug Discovery Reduce Senescence and Improve Multiple Markers of Healthspan
06-oct-2026 novelty 3 per-area 3 strengthens
pubmed review expert-opinion
Therapeutic reversal of cellular senescence: A systematic review of senolytics, senomorphics and anti-ageing therapies in human clinical trials.
05-oct-2026 novelty 3 per-area 3 strengthens
pubmed preclinical mechanism-plausible
Senotherapeutic potential against xeroderma pigmentosum.
05-oct-2026 novelty 3 per-area 3 strengthens
pubmed review
Cellular senescence: six decades of discovery and reinvention.
02-oct-2026 novelty 2 per-area 2 mentions
pubmed review mechanism-plausible
Endothelial TLR4 at the Crossroads of Vascular Senescence and Targeted Senotherapeutics.
01-oct-2026 novelty 3 per-area 3 strengthens
pubmed preclinical animal-model
Targeting senescence-associated fibrotic signatures identifies syringin as an effective modulator of the ATR/CHK1-p53 axis in idiopathic pulmonary fibrosis.
01-oct-2026 novelty 3 per-area 3 strengthens
pubmed review
Wound Healing, Senescence, and Senotherapeutics.
30-sep-2026 novelty 2 per-area 2 strengthens
pubmed review
Berberine as a multi-hallmark modulator of aging: From AMPK and mitophagy to inflammaging and the SASP.
28-sep-2026 novelty 2 per-area 2 strengthens
pubmed review
Stem cell senescence as a regenerative bottleneck in age-related skeletal degeneration: Mechanistic crosstalk and translational strategies.
27-sep-2026 novelty 2 per-area 2 strengthens
pubmed review
Senescence-associated extracellular vesicles in skin aging and regeneration: from pathophysiology to therapeutic opportunities.
22-sep-2026 novelty 2 per-area 2 strengthens
pubmed review
Cellular senescence and the SASP in skeletal ageing: convergent mechanisms of progressive bone loss in osteoporosis.
22-sep-2026 novelty 2 per-area 2 strengthens
pubmed review
Schisandra chinensis Modulates Cellular Senescence through Integrated Regulation of Redox, Mitochondrial, and Inflammatory Homeostasis.
19-sep-2026 novelty 2 per-area 2 strengthens
pubmed review
Therapeutic Targeting of Inflammaging and Emerging Strategies for Managing Age-Related Multimorbidity: A Narrative Review.
19-sep-2026 novelty 2 per-area 2 strengthens
pubmed review
Cellular Senescence and SASP in Bladder Ageing: Mechanisms and Emerging Interventions.
17-sep-2026 novelty 2 per-area 2 strengthens
pubmed review
Multidimensional Regulatory Network of Cellular Senescence: From Mechanisms to Theranostics.
15-sep-2026 novelty 2 per-area 2 mentions
pubmed review
The vicious cycle of SASP and inflammaging promotes aging and age-related diseases.
10-sep-2026 novelty 2 per-area 2 mentions
pubmed preclinical mechanism-plausible
Senescent cardiac cells promote thrombus formation and impair fibrinolysis.
01-aug-2026 novelty 3 per-area 3 strengthens
pubmed review mechanism-plausible
Complosome as a key modulator of cellular senescence, aging and age-related diseases.
29-jul-2026 novelty 3 per-area 3 strengthens
pubmed review
Senomorphic agents: Multi-target strategies to tame the senescence-associated secretory phenotype for healthy ageing.
24-jul-2026 novelty 2 per-area 3 strengthens
pubmed review
Natural products targeting cytokine-regulated SASP inflammation networks in Ovarian cancer: Implications on immune escape and molecular resistance.
21-jul-2026 novelty 2 per-area 2 strengthens
pubmed review
Cleaning, Chasing and Calming: Promising Paradigms of Senotherapy in Aging-Related Diseases.
20-jul-2026 novelty 2 per-area 2 introduces
pubmed preclinical animal-model
Discovery of a quinoline-based senomorphic agent for the treatment of chronic kidney disease.
17-jul-2026 novelty 3 per-area 3 strengthens
pubmed review expert-opinion
A compendium of circulating biomarkers of senescence in humans: Insights on mechanistic impact across health domains and modulation by therapeutic interventions.
14-jul-2026 novelty 3 per-area 3 strengthens
pubmed preclinical animal-model
Targeting the JAK-STAT signaling pathway ameliorates chemotherapy-induced skin aging.
12-jul-2026 novelty 3 per-area 3 strengthens
pubmed review
The role of cellular senescence in metabolic dysfunction-associated steatotic liver disease.
09-jul-2026 novelty 2 per-area 2 strengthens
pubmed review
Targeting cellular senescence in dermatology: senolytic and senomorphic strategies.
08-jul-2026 novelty 2 per-area 2 introduces
pubmed review
Cellular Senescence and Aging: Mechanisms, Disease Convergence, and Therapeutic Frontiers.
05-jul-2026 novelty 2 per-area 2 strengthens
pubmed review
From lifespan extension to hallmark-informed gerotherapeutic prioritization: A bibliometric-guided, strategy-oriented review of anti-aging drug research.
28-jun-2026 novelty 3 per-area 2 strengthens
pubmed review
Advances in skin aging: integrating epigenetic, cellular, and immune mechanisms for targeted therapy.
24-jun-2026 novelty 2 per-area 2 mentions
pubmed review mechanism-plausible
Hydrogel-based senomorphic approaches to modulate cellular senescence and promote tissue rejuvenation.
23-jun-2026 novelty 3 per-area 3 strengthens
pubmed review
Immunosenescence in systemic and multi-organ aging: mechanisms, inter-organ crosstalk, and translational opportunities.
19-jun-2026 novelty 2 per-area 2 mentions
pubmed review
Cellular senescence in Crohn's disease: a double-edged sword in intestinal fibrosis.
12-jun-2026 novelty 2 per-area 2 mentions
pubmed review
Novel therapeutic strategies for osteoarthritis: from mechanistic insights to precision medicine.
11-jun-2026 novelty 2 per-area 3 strengthens
pubmed review mechanism-plausible
Cell senescence in chronic pain: An integrative perspective on cellular and neural mechanisms.
30-may-2026 novelty 3 per-area 3 strengthens
pubmed preclinical animal-model
circRNA-engineered macrophages mediate localized MMP9 neutralization to rejuvenate aged bone.
22-may-2026 novelty 4 per-area 4 strengthens
pubmed review
Epigenetic dynamics of cellular senescence: From mechanistic insights to precision senotherapy.
17-mar-2026 novelty 2 per-area 2 strengthens

build build 880 · 2bcef25 · 2026-11-18